RESUMO
OBJECTIVE: The objective of this study was to determine the skin barrier changes during postnatal month 1 among infants receiving routine mustard oil massage in the humid conditions of rural Nepal. STUDY DESIGN: This was an observational study among 500 live-born neonates receiving mustard oil massage. Skin integrity such as erythema, rash, dryness, skin pH, stratum corneum protein concentration and transepidermal water loss was measured on days 1, 3, 7, 14 and 28. RESULTS: Erythema and rash increased (worsened) during weeks 1 and 2, then decreased over weeks 3 and 4. Skin pH (6.1±0.5 to 5.0±0.6) and stratum corneum protein (16.6±7.9 to 13.5±5.9 µg cm-2) decreased. Transepidermal water loss increased from 33.2±23.5 to 43.0±24.5 g m-2 h-1 at day 28. Skin pH and stratum corneum protein were higher for early versus late premature infants. CONCLUSION: Premature and full-term skin condition was generally poor especially during the first 2 weeks, improving thereafter. Maturational changes were evident.
Assuntos
Epiderme/metabolismo , Eritema/fisiopatologia , Massagem/métodos , Mostardeira/efeitos adversos , Óleos de Plantas/efeitos adversos , Perda Insensível de Água/fisiologia , Administração Tópica , Emolientes/efeitos adversos , Feminino , Proteínas Filagrinas , Idade Gestacional , Humanos , Concentração de Íons de Hidrogênio , Recém-Nascido , Proteínas de Filamentos Intermediários/análise , Masculino , Nepal , Ensaios Clínicos Controlados Aleatórios como Assunto , População RuralRESUMO
BACKGROUND: Fractional lasers were introduced to provide increased safety, while maintaining high efficacy and patient satisfaction. Patients with virtually all Fitzpatrick skin types could be safely treated using a wide spectrum of wavelengths and a broad array of skin conditions, and aging could be addressed. Although safety studies have been reported for ablative CO2 and erbium lasers, surprisingly few data are available on adverse events and complications associated with fractional lasers. OBJECTIVE: We report the frequency of adverse events, skin improvement and complications in a broad range of skin types using a standardized protocol that can be safely tailored to the patient's presenting complaints by varying the laser wavelength and number of treatments. MATERIALS AND METHODS: The medical records of 730 patients (>90% females, age ranged from 50.5. to 59.9 years.) who had been treated at FACES+ Aesthetic Facility were reviewed. Patients were followed from 1 to 10 months and were reviewed to determine the frequency of complications, as well as their frequency, type, cause, treatment and resolution thereof. Patients were categorized by Fitzpatrick skin type (I-IV) to determine whether skin type was related to the frequency of complications. Improvement in skin condition (wrinkles, nasolabial folds and pigment) was rated by a technician before and after treatment using a Likert scale, 0-5, with 0 being no change and 5 being the most improvement. RESULTS: Seven hundred thirty patients underwent procedures using fractional lasers in our center. Procedures were carried out with 3 different laser wavelengths, depending on the condition(s) treated (wrinkling vs. pigmentation issues, etc.) and the patients' desired length of downtime. The fractional Fraxel 1927-nm laser was used in 224 patients [Fitzpatrick skin type I (2.2%), II (38.4%), III (46.0%), IV (12.5%)]; the fractional Fraxel 1550-nm laser was used in 334 [type I (4.5%), II (31.9%), III (50.0%), IV (13.3%)], and the fractional Fraxel CO2 laser was used in 172 [type 1 (4.7%), II (49.7%), III (41.5%), IV (4.1%)]. The Fraxel CO2 laser showed greater improvement in wrinkles and naso-labial fold (p < 0.001). The greatest improvement in pigmentation was seen with the Fraxel 1927-nm laser (p < 0.001). Adverse events and complications occurred in 31 of 730 patients (4.2%). There was no significant difference in the rate of complications among the three treatments (p = 0.26). Complications were generally minor, and all resolved completely with treatment. Complications occurred in 4.0% of patients having the fractional Fraxel 1927-nm laser, 3.3% of patients having the fractional Fraxel 1550 nm and 6.4% of patients having the fractional Fraxel CO2 laser. Complications included 5 herpes simplex virus breakouts, 13 acne eruptions, 1 abrasion, 1 bacterial infection, 9 dermatitis, 1 drug eruption, 4 prolonged erythema, 1 hyperpigmentation, 1 increased swelling and 1 telangiectasia. There was no significant relationship between Fitzpatrick skin type and incidence of complications (p = 0.37). CONCLUSIONS: Fractional lasers in general have reduced complication rates, while maintaining high degrees of patient satisfaction. Since their inception in early 2004, our clinic has utilized fractional lasers to treat patients from a variety of ethnic backgrounds and diverse skin types with an overall complication rate of 4.2%, all of which resolved. Comprehensive care of patients with facial aging is not limited to surgery alone and should include these types of strategies to appropriately and safely address photo-damage and photo-aging. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Assuntos
Lasers de Gás , Lasers de Estado Sólido , Terapia com Luz de Baixa Intensidade/efeitos adversos , Terapia com Luz de Baixa Intensidade/métodos , Satisfação do Paciente/estatística & dados numéricos , Técnicas Cosméticas , Bases de Dados Factuais , Edema/etiologia , Edema/fisiopatologia , Eritema/etiologia , Eritema/fisiopatologia , Estética , Feminino , Humanos , Hiperpigmentação/diagnóstico , Hiperpigmentação/radioterapia , Masculino , Seleção de Pacientes , Estudos Retrospectivos , Medição de Risco , Envelhecimento da Pele , Resultado do TratamentoRESUMO
Scarring is the response elicited by the skin surface to injury and loss of tissue material. Wound healing takes place through a complex natural repair system consisting of vascular, inflammatory and proliferative phenomena, followed by a remodelling and cell apoptosis phase. This incredible repair system is inevitable, but sometimes unpredictable due to individual differences based on multiple factors. The scar is the objective criterion of a skin surgery, both for the patient and the dermsurgeon. It is therefore crucial to establish with the patient during the preoperative consultation, the size and positioning of the expected scar, taking into account the oncologic, anatomic and surgical constraints. Scars can ideally blend into normal skin, but may also give rise to various abnormalities. We can manage and prevent these abnormalities by mastering initial inflammation, that may induce hyperpigmentation and hypertrophy. Early massage using cortocosteroid topic or anti-inflammatory moisturizers may be effective. Random individual scarring may be minimized by a dynamic personalized accompanying scarring.
Assuntos
Cicatriz/fisiopatologia , Procedimentos Cirúrgicos Dermatológicos/efeitos adversos , Corticosteroides/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Cicatriz/prevenção & controle , Cicatriz Hipertrófica/fisiopatologia , Cicatriz Hipertrófica/prevenção & controle , Terapia Combinada , Eritema/fisiopatologia , Eritema/prevenção & controle , Hiperpigmentação/fisiopatologia , Hiperpigmentação/prevenção & controle , Queloide/fisiopatologia , Massagem , Educação de Pacientes como Assunto , Fatores de Risco , Pele/fisiopatologia , Transplante de Pele , Protetores Solares/administração & dosagem , Telangiectasia/fisiopatologia , Telangiectasia/prevenção & controle , Cicatrização/fisiologiaRESUMO
Negative pressure of cupping induces skin deformation such as ecchymosis and purpura in a circular shape. Thus, there is a desire to treat skin before depigmentation and scarring occurs. Therefore, we introduce laser therapy, a widely used technique treat pigmentation in dermatology. Various parameters of laser therapy can be applied, so to determine the optimal exposure parameters that do not damage the surrounding tissues, the subjects were divided into four groups: a non-stimulation group and three laser groups (4 J/cm2 group, 6 J/cm2 group, and 8 J/cm2 group). We selected the wavelength and output of laser as follows: 660nm and 50mW. The 40 were divided into four groups of 10. In the first experiment, we measured skin temperature using Digital infrared thermography in order to observe whether the laser could cause heat damage. In the second experiment, each group received the assigned laser therapy protocol every 24 hours for 72 hours. We obtained a skin image using a cross polarization technique. Previous studies have shown that a*and E.I (erythema index) represent the degree of skin erythema (hemoglobin content). M.I (melanin index) indicates the degree of skin pigmentation (melanin content). Hence, skin color information was analyzed with the a*, erythema index (E.I), and melanin index (M.I) for 72 hours. None of the laser exposure parameters led to skin damage by heating or energy dissipation. The results of a*, E.I, and M.I of all groups showed the different recovery rates towards the normal skin color information before cupping. As energy density increases, the result of a* and E.I showed the fast recovery rate. There was no significant different between M.I at non-stimulation group and M.I at 4 J/cm². Therefore, the least energy density as 6 J/cm² is need for the recovery of melanin content. The a*, E.I, and M.I at 8 J/cm² group rather than other groups were significantly recovered to normal skin color. In conclusion, the laser therapy (energy density: 8 J/cm²) has a significant recovery of the skin erythema and skin pigmentation except to skin damage.
Assuntos
Eritema/terapia , Terapia a Laser , Púrpura/terapia , Terapia por Acupuntura , Adulto , Terapia Combinada , Eritema/fisiopatologia , Humanos , Masculino , Projetos Piloto , Púrpura/fisiopatologia , Pele/fisiopatologia , Pigmentação da Pele , Temperatura Cutânea , Adulto JovemAssuntos
Gordura Abdominal , Eritema/etiologia , Obesidade/terapia , Banho a Vapor/instrumentação , Adulto , Dermatite de Contato/etiologia , Dermatite de Contato/fisiopatologia , Eritema/fisiopatologia , Feminino , Seguimentos , Humanos , Medição de Risco , Banho a Vapor/efeitos adversos , Redução de PesoRESUMO
Extracts of Tanacetum parthenium (L.) Sch. Bip., a plant known under the common name "Feverfew", contains the sesquiterpene lactone parthenolide, a potent skin sensitizer. To eliminate the risk of skin sensitization from Feverfew, we developed a parthenolide-depleted extract of Feverfew (PD-Feverfew) and determined its effectiveness as an anti-inflammatory agent. We confirmed that PD-Feverfew was sufficiently depleted of parthenolide since PD-Feverfew did not inhibit TNF-alpha induced-NF-kappaB activity unlike parthenolide containing whole Feverfew. PD-Feverfew directly inhibited the activity of pro-inflammatory enzymes 5-lipoxygenase, phosphodiesterase-3 and phosphodiesterase-4. PD-Feverfew inhibited the release of pro-inflammatory mediators nitric oxide, PGE(2) and TNF-alpha from macrophages and TNF-alpha, IL-2, IFN-gamma and IL-4 from human peripheral blood mononuclear cells. Additionally, PD-Feverfew inhibited TPA-induced release of PGE(2) from human skin equivalents. In vivo, PD-Feverfew inhibited oxazolone-induced dermatitis, and was more potent than whole Feverfew in reducing TPA-induced dermatitis. Finally the efficacy of PD-Feverfew was confirmed clinically by a reduction in erythema in a methyl nicotinate-induced vasodilation model. In conclusion, our results indicate that PD-Feverfew extracts have potent anti-inflammatory activity suggesting that this botanical would be efficacious in relieving inflammation without inducing immune sensitization.
Assuntos
Anti-Inflamatórios/farmacologia , Inflamação/tratamento farmacológico , Extratos Vegetais/farmacologia , Tanacetum parthenium/química , Adulto , Animais , Anti-Inflamatórios/isolamento & purificação , Células Cultivadas , Dermatite/tratamento farmacológico , Dermatite/fisiopatologia , Eritema/tratamento farmacológico , Eritema/fisiopatologia , Feminino , Humanos , Inflamação/fisiopatologia , Mediadores da Inflamação/metabolismo , Queratinócitos/efeitos dos fármacos , Queratinócitos/metabolismo , Leucócitos Mononucleares/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Camundongos , Pessoa de Meia-Idade , Sesquiterpenos/isolamento & purificação , Sesquiterpenos/toxicidade , Adulto JovemAssuntos
Eritema/etiologia , Temperatura Alta/efeitos adversos , Lasers/efeitos adversos , Terapia com Luz de Baixa Intensidade/efeitos adversos , Adulto , Eritema/fisiopatologia , Seguimentos , Humanos , Terapia com Luz de Baixa Intensidade/métodos , Masculino , Recidiva , Remissão Espontânea , Medição de Risco , Fatores de TempoRESUMO
BACKGROUND AND OBJECTIVES: The pulsed dye laser set the standard of care for the treatment of vascular lesions, and recent modifications have enabled improved efficacy with fewer side effects. An investigational high energy, variable pulse duration pulsed dye laser has been modified to treat both vascular and pigmented lesions associated with photoaging. Each laser pulse is comprised of a sequence of eight uniform micropulses, which evenly distribute the pulse energy, effectively increasing the purpura threshold at any given fluence. Pigmented lesions are treated with a compression handpiece (CHP) that removes competing vascular target from the field, and helps to prevent purpura. This pilot study was undertaken to determine the optimum laser settings, and to investigate the ability of this device to improve vascular and pigmented lesions associated with photoaging. STUDY DESIGN/MATERIALS AND METHODS: Twenty-four patients with photoaged skin and phototype I-III were enrolled in the study. Thirteen received treatment for vascular and pigmented lesions, and 11 subjects were treated for pigmented lesions alone. Subjects received one to three treatments at 3-4 weeks intervals, and underwent 3- and 12-week follow-up evaluation. The degree of improvement was assessed by subject evaluation as well as comparison of standardized digital photographs by three independent dermatologists. Background erythema was treated with a 12-mm spot size, at a fluence of 7 J/cm(2), and a pulse width of 10 ms. The cryogen cooling was set at 30 mseconds with a 30 ms delay. Individual telangiectasias were treated with a 5- or 7-mm spot size at fluences of 9-14 J/cm(2) and pulse widths of 6-20 mseconds. Pigmented lesions were treated using a 5- or 7-mm spot size, with energy of 9-15 J/cm(2) and a pulse width of 1.5-10 ms without cooling. The CHP had a 7-mm spot size, and fluences of 9-16 J/cm(2), and pulse widths of 1.5 or 3 ms were used in the treatment of pigmented lesions. RESULTS: The treatment was well tolerated without the use of topical anesthetic. All subjects noted improvement in the both vascular and pigmented lesions, and were satisfied with their outcomes. Objectively, there was moderate improvement in background erythema, telangiectasia, and pigmented lesions. Three subjects who were treated with sun tans developed transient hypopigmentation and two subjects developed a transient textural change following pulse stacking for the treatment of pigmented lesions with the conventional handpiece. Purpura was noted in all patients treated for pigment with the conventional handpiece at pulsewidths less than 6 mseconds, as compared to only one that was treated with the CHP. Three patients treated in rapid succession for vascular, and then pigmented lesions with the CHP exhibited purpura, which was prevented in future treatments with 1-2 minutes of topical ice cooling between passes. CONCLUSIONS: This novel 595-nm pulsed dye laser, with a modified pulse sequence and CHP, now has the versatility to safely treat both pigment and vascular changes associated with photoaging.
Assuntos
Terapia com Luz de Baixa Intensidade/instrumentação , Transtornos da Pigmentação/radioterapia , Envelhecimento da Pele , Dermatopatias Vasculares/radioterapia , Adulto , Idoso , Temperatura Baixa , Desenho de Equipamento , Eritema/fisiopatologia , Eritema/terapia , Feminino , Seguimentos , Humanos , Hipopigmentação/etiologia , Terapia com Luz de Baixa Intensidade/efeitos adversos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Fotografação , Transtornos da Pigmentação/fisiopatologia , Projetos Piloto , Púrpura/etiologia , Dermatopatias Vasculares/fisiopatologia , Inquéritos e Questionários , Fatores de Tempo , Resultado do TratamentoRESUMO
We have studied the cutaneous response to ultraviolet radiation, measured objectively as erythema in a sample of 12 body sites on 15 Northern European subjects with multiple doses of ultraviolet B (UVB). Skin pigmentation and the development of photoadaptation in response to five repeated doses of irradiation at three body sites was also measured. We report striking differences of up to 5-fold at different body sites to the same challenge dose (p < 0.001) and demonstrate that for this population, site variation is just as important as between-person variation. Skin color at each body site is a strong predictor of response (p < 0.001) and that this cannot be attributed to vascular differences, but instead we believe it reflects site-specific variations in melanin pigmentation. We also observed similar but smaller within-person effects for responses to another inflammatory agent, dithranol (p < 0.01). Despite this, we did not find evidence for differences in the development of photoadaptation by body site. These results have clear clinical implications for the practice of phototesting prior to commencing phototherapy, for therapeutic failure in sites such as the legs in patients with psoriasis, and perhaps for melanoma body-site distribution.
Assuntos
Adaptação Fisiológica/efeitos da radiação , Eritema/fisiopatologia , Pigmentação da Pele/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Adaptação Fisiológica/fisiologia , Adolescente , Adulto , Antralina/administração & dosagem , Anti-Inflamatórios/administração & dosagem , Relação Dose-Resposta à Radiação , Eritema/tratamento farmacológico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fluxo Sanguíneo Regional/efeitos dos fármacos , Pele/irrigação sanguínea , Pele/efeitos da radiação , Pigmentação da Pele/fisiologiaRESUMO
INTRODUCTION: The aim of the study was to investigate the hypoalgesic effects of a single spinal manipulation treatment on acute inflammatory reactions and pain induced by cutaneous application of capsaicin. METHODS: Twenty healthy subjects participated in the experiment, which consisted of 2 sessions. In both sessions, following control measurements, topical capsaicin was applied to the right or left forearm to induce cutaneous inflammatory reactions. The cream was removed after 20 minutes. Then subjects received either spinal manipulation treatment (SMT) or "nonspinal manipulation treatment" (N-SMT), respectively. In control as well as pretreatment and posttreatment intervals, the following tests were performed: measurement of the areas of mechanical hyperalgesia and stroking allodynia, assessment of spontaneous pain, and measurement of blood flow. RESULTS: The results confirmed that topical capsaicin induced inflammatory reactions based on occurrence of hyperalgesia and allodynia, augmented pain perception, and increased blood flow following capsaicin application compared with the control session. When compared with N-SMT, spontaneous pain was rated significantly lower post-SMT (P <.014). In addition, areas of both secondary hyperalgesia and allodynia decreased after SMT (hyperalgesia: P <.007; allodynia: P <.003). However, there was no significant treatment effect for local blood flow. CONCLUSION: These results suggest hypoalgesic effects following a single SMT. As local vascular parameter was not affected by the single SMT, the hypoalgesic effects appear to be due to central mechanisms.
Assuntos
Capsaicina/toxicidade , Eritema/prevenção & controle , Hiperalgesia/prevenção & controle , Irritantes/toxicidade , Manipulação Quiroprática , Administração Cutânea , Adulto , Capsaicina/administração & dosagem , Eritema/induzido quimicamente , Eritema/fisiopatologia , Feminino , Humanos , Hiperalgesia/induzido quimicamente , Hiperalgesia/fisiopatologia , Irritantes/administração & dosagem , Masculino , Microcirculação/efeitos dos fármacos , Modelos Neurológicos , Medição da Dor , Método Simples-Cego , Pele/irrigação sanguínea , Pele/efeitos dos fármacos , Estresse Mecânico , TatoRESUMO
Up to now, there are only a few data available concerning the influence of bathing time on skin phototoxicity. We compared the erythemal responses of normal skin to bath PUVA with 8-methoxypsoralen (8-MOP) after 5, 10 and 20 min immersion time. Currently, 20 min is the routinely performed immersion time in many European countries, including Germany, while in other countries bathing times are shorter. The minimal phototoxic dose (MPD) following immersion times of 5 min and 10 min in a warm water bath (37 degrees C) containing 1 mg/l 8-MOP was compared to the MPD following 20 min immersion time in a half-sided manner in a total of 24 patients. Our results revealed that an immersion time of 5 min did not yield a detectable erythema after 72 h. In contrast, both 10 and 20 min PUVA baths induced visible erythemas with a significantly higher median MPD following 10 min immersion (2.25 J/cm2) compared to 20 min baths (1.5 J/cm2). As an erythemal response of 8-MOP PUVA bath seems reduced after shorter immersion times, comparative studies on the clinical efficacy using shorter time regimens have to be conducted before conclusive recommendations for clinical PUVA-bathing time can be given.
Assuntos
Metoxaleno/farmacologia , Terapia PUVA/métodos , Fármacos Fotossensibilizantes/farmacologia , Dermatopatias Papuloescamosas/tratamento farmacológico , Banhos , Relação Dose-Resposta a Droga , Eritema/etiologia , Eritema/fisiopatologia , Feminino , Seguimentos , Humanos , Imersão , Masculino , Metoxaleno/uso terapêutico , Terapia PUVA/efeitos adversos , Fármacos Fotossensibilizantes/uso terapêutico , Probabilidade , Estudos Prospectivos , Psoríase/diagnóstico , Psoríase/terapia , Índice de Gravidade de Doença , Pele/efeitos dos fármacos , Pele/efeitos da radiação , Dermatopatias Papuloescamosas/diagnóstico , Testes Cutâneos , Estatísticas não Paramétricas , Fatores de Tempo , Resultado do TratamentoRESUMO
Optimization of the PUVA regime requires knowledge of the time-course and dose-response characteristics of PUVA erythema. Although existing guidelines recommend determination of the minimal phototoxic dose (MPD) 72 hours after UVA exposure and treatment administered 72 hours apart, recent evidence suggests that maximal PUVA erythema occurs beyond this time point, and hence the current assessment time underestimates the phototoxic effect of PUVA. This report reviews the current literature, including the authors' own experience of the characteristics of PUVA erythema, and recommends that the optimal time to read the PUVA MPD is 96 h.
Assuntos
Eritema/etiologia , Eritema/patologia , Terapia PUVA/efeitos adversos , Fármacos Fotossensibilizantes/efeitos adversos , Relação Dose-Resposta a Droga , Relação Dose-Resposta à Radiação , Eritema/fisiopatologia , Humanos , Fármacos Fotossensibilizantes/administração & dosagemRESUMO
BACKGROUND: In animal models, extracts from green tea have been shown to be remarkably effective at reducing the severity of adverse human health effects of overexposure to ultraviolet (UV) radiation. Although sunscreens and other photoprotective measures have traditionally been used for this purpose, there is a need for additional measures and natural products are increasingly being explored for that purpose. OBJECTIVE: Our purpose was to evaluate the effect of polyphenols from green tea on parameters associated with acute UV injury. METHODS: Areas of skin of normal volunteers were treated with an extract of green tea or one of its constituents. Thirty minutes later, the treated sites were exposed to a 2 minimal erythema dose solar simulated radiation. UV-treated skin was examined clinically for UV-induced erythema, histologically for the presence of sunburn cells or Langerhans cell distributions, or biochemically for UV-induced DNA damage. RESULTS: Application of green tea extracts resulted in a dose-dependent inhibition of the erythema response evoked by UV radiation. The (-)-epigallocatechin-3-gallate (EGCG) and (-)-epicatechin-3-gallate (ECG) polyphenolic fractions were most efficient at inhibiting erythema, whereas (-)-epigallocatechin (EGC) and (-)-epicatechin (EC) had little effect. On histologic examination, skin treated with green tea extracts reduced the number of sunburn cells and protected epidermal Langerhans cells from UV damage. Green tea extracts also reduced the DNA damage that formed after UV radiation. CONCLUSION: Polyphenolic extracts of green tea are effective chemopreventive agents for many of the adverse effects of sunlight on human health and may thus serve as natural alternatives for photoprotection.
Assuntos
Flavonoides , Fenóis/farmacologia , Polímeros/farmacologia , Queimadura Solar/prevenção & controle , Protetores Solares/farmacologia , Chá/química , Raios Ultravioleta/efeitos adversos , Administração Tópica , Adolescente , Adulto , Quimioprevenção , Dano ao DNA , Relação Dose-Resposta a Droga , Eritema/fisiopatologia , Eritema/prevenção & controle , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polifenóis , Pele/patologia , Queimadura Solar/fisiopatologiaRESUMO
BACKGROUND: Psoriasis is a chronic T-cell-mediated inflammatory skin disease which can be treated with topical medication, phototherapy or systemic medication. A subgroup of psoriatic patients does not respond to monotherapy and needs combination therapy. We used low-dose narrow-band UVB phototherapy, combined with balneotherapy, short-contact anthralin, liquor carbonis detergens and calcipotriol for treatment of psoriatic patients in our day care centre. OBJECTIVE: Our purpose was to study the efficacy, induction of erythema and effect on systemic T-cell activation of this combination therapy. METHODS: Skin reflectance spectrophotometry was used to measure skin erythema. The Psoriasis Area and Severity Index (PASI) was used to evaluate psoriatic patients. Serum soluble IL-2 receptor (sIL2-R) levels were measured by an ELISA. RESULTS: The possible erythematogenic effect of low-dose narrow-band UVB irradiation was studied (skin reflectance spectrophotometer) in a control group of psoriatic patients (n = 11). No induction of skin erythema was seen. Subsequently, this low-dose irradiation regimen was used in combination with topical medication in 26 psoriatic patients. A 90% decrease in the PASI was seen after a mean number of 35 treatment sessions. Seventeen patients (65%) remained in remission during the following 6 months. Serum sIL-2R levels were elevated in all patients (mean 913 U/ml) and did not change during treatment. CONCLUSION: Our data indicate that low-dose narrow-band UVB can be used successfully, in combination with topical treatment, in a day care setting to treat psoriatic patients. Since sIL-2R serum levels were not decreased, it can be speculated that this treatment does not induce systemic immunosuppression.
Assuntos
Anti-Inflamatórios/uso terapêutico , Psoríase/terapia , Linfócitos T/imunologia , Terapia Ultravioleta , Administração Tópica , Adolescente , Adulto , Idoso , Antralina/efeitos adversos , Antralina/uso terapêutico , Anti-Inflamatórios/efeitos adversos , Balneologia , Calcitriol/efeitos adversos , Calcitriol/análogos & derivados , Calcitriol/uso terapêutico , Terapia Combinada , Fármacos Dermatológicos/efeitos adversos , Fármacos Dermatológicos/uso terapêutico , Relação Dose-Resposta à Radiação , Eritema/etiologia , Eritema/fisiopatologia , Humanos , Ativação Linfocitária/efeitos dos fármacos , Ativação Linfocitária/efeitos da radiação , Pessoa de Meia-Idade , Psoríase/sangue , Receptores de Interleucina-2/sangue , Índice de Gravidade de Doença , Solubilidade , Linfócitos T/efeitos dos fármacos , Linfócitos T/efeitos da radiação , Resultado do Tratamento , Terapia Ultravioleta/efeitos adversosRESUMO
OBJECTIVE: Patients in the neonatal intensive care unit require life support and monitoring equipment that must be securely attached to the skin; removal or replacement often causes skin trauma. In this study, we compared the effects of application and removal of three different adhesives on the skin barrier function of premature neonates. The effects were measured by transepidermal water loss (TEWL), colorimetric measurements, and visual inspection. DESIGN: Thirty neonates, between 26 and 40 weeks of gestational age and with birth weights ranging from 690 to 3000 gm, were enrolled in the study during the first week of life. Pieces of plastic tape (1 cm2), pectin barrier, and hydrophilic gel were applied to previously undisturbed sites on the back. A fourth site was used as a control. We measured TEWL, colorimetric readings, and visual inspection scores of skin irritation and stripping at each of the four sites serially: before adhesive application, 30 minutes after adhesive removal, and 24 hours later. RESULTS: Thirty minutes after adhesive removal, TEWL, colorimetric measurements, and visual inspection scores were all significantly higher at the sites of plastic tape and pectin barrier removal than at the control and gel adhesive sites (p < 0.01), demonstrating greater disruption of skin barrier function with removal of the plastic tape and pectin barrier. When the neonates were divided into three groups on the basis of birth weight (< 1000 gm [n = 10], 1000 to 1500 gm [n = 11], and > 1500 gm [n = 9], the same pattern of greater disruption in skin barrier function, as measured by TEWL, was observed in each birth weight group. Twenty-four hours after adhesive removal, TEWL of the plastic tape and pectin barrier sites were not significantly different from the control site, indicating recovery of skin barrier function. CONCLUSIONS: This study demonstrates that a single application and removal of two commonly used adhesives, plastic tape and pectin barrier, disrupts skin barrier function in neonates of varying gestational ages.
Assuntos
Adesivos/efeitos adversos , Eritema/etiologia , Recém-Nascido Prematuro , Pele/lesões , Adesivos/classificação , Peso ao Nascer , Colorimetria , Eritema/diagnóstico , Eritema/fisiopatologia , Géis , Idade Gestacional , Humanos , Recém-Nascido , Terapia Intensiva Neonatal , Pectinas , Fatores de Tempo , Perda Insensível de ÁguaRESUMO
Results from both animal and human studies have indicated that inflammatory skin reactions such as the flare response to histamine prick test involve a neurogenic regulatory component. It is still unknown to which degree inflammation induced by ultraviolet (UV) radiation may be mediated by the central nervous system. To investigate this, the effect of hypnotic suggestions to increase and decrease the response to UVB radiation on erythema and cutaneous blood flow was investigated in 10 highly hypnotizable subjects. The results showed a significant effect of hypnotic suggestions on cutaneous blood flow compared with the responses of a control group. For erythema no conclusive evidence was found. The results indicate the possibility of separate regulatory mechanisms behind central nervous system influence on UVB-induced erythema and skin blood flow respectively, and further investigations are needed.
Assuntos
Eritema/etiologia , Eritema/psicologia , Hipnose , Pele/irrigação sanguínea , Pele/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Adulto , Capilares/inervação , Capilares/fisiologia , Capilares/efeitos da radiação , Eritema/fisiopatologia , Feminino , Antebraço/efeitos da radiação , Histamina , Humanos , Hipnose Anestésica , Fluxometria por Laser-Doppler , Masculino , Fluxo Sanguíneo Regional/fisiologia , Fluxo Sanguíneo Regional/efeitos da radiação , Método Simples-Cego , Pele/inervação , Testes Cutâneos , Espectrofotometria , Vasodilatação/fisiologia , Vasodilatação/efeitos da radiação , Sistema Vasomotor/fisiologia , Sistema Vasomotor/efeitos da radiaçãoRESUMO
Several gold salts were compared in kaolin-induced rat paw oedema, u.v. erythema in guinea pigs, delayed type hypersensitivity and humoral immunity in mice, and adjuvant-induced arthritis in the rat. In the latter the additional parameters of serum gold and copper levels and lysosomal enzyme activity were determined. In addition, the in vitro inhibition of several lysosomal enzymes derived from mouse macrophages was studied. The gold compounds examined were aurothiomalate, aurothioglucose, triethylphosphine gold chloride (SK & F 36914) and its glucopyranoside derivative (SK & F D-39162), triphenylphosphine gold chloride and sodium gold chloride dihydrate. SK & F 36914 and SK & F D-39162 has significant activity after oral dosage upon paw kaolin and u.v. erythema in rats and guinea pigs, respectively. Gastric swelling also occurred. In Wistar rats, adjuvant arthritis was little affected by the gold salts but in the Lewis rats there was suppression. In both strains there was less elevation in serum copper levels with treatment by SK & F 36914 and SK & F D-39162, but not by aurothiomalate. None of the compounds had any measurable effect on delayed hypersensitivity or humoral antibody levels in mice. The in vitro activities of cathepsin B1 and cathepsin D were inhibited by all the gold compounds. Reactivity of gold compounds with glutathione and cysteine in vitro was dependent on compound solubility and the nature of the gold ligand. Considerable differences exist between the profiles of activity for the different gold salts evaluated. These observations indicate that some gold salts do possess anti-inflammatory activity with a potency similar to that of indomethacin.
Assuntos
Ouro/farmacologia , Imunidade/efeitos dos fármacos , Inflamação/fisiopatologia , Animais , Formação de Anticorpos/efeitos dos fármacos , Artrite Experimental/fisiopatologia , Cisteína , Edema/induzido quimicamente , Edema/fisiopatologia , Eritema/fisiopatologia , Glutationa , Cobaias , Hipersensibilidade Tardia/imunologia , Caulim , Lisossomos/efeitos dos fármacos , Lisossomos/enzimologia , Masculino , Camundongos , Ratos , Raios UltravioletaRESUMO
Since the rediscovery of willow bark extract (salicin) in 1763, there has been a continuing effort to improve efficacy and reduce the side effects of antiinflammatory agents through chemical modification and innovation. The second-generation NSAIA's, phenylbutazone and indomethacin, provided clear support for the idea that these objectives were obtainable. The success of steroid programs in enhancing potency and modifying side effects, coupled with the development of effective screening techniques for identifying antiinflammatory activity, stimulated an enormous effort to develop new NSAIA's. The products of this effort are now coming to the clinic. Although less successful than the steroid program in enhancing potency, the effort has succeeded in changing and reducing side effects. As a result, the clinician has a greater choice of agents for dealing with individual patient variability and achieving greater patient acceptance.